Hemophilia A or B: Clinical Trials

5 trials for Hemophilia A or B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Recruiting 1

Follow Hemophilia A or B: new trials by email Literature Review of Hemophilia A or B trials Research Report on Hemophilia A or B

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Describe Patient REal-world FitusiRan ExpeRience
Hemophilia A or B
Not yet recruitingSanofi1002026-10-072026-10-26
Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
KN057 - Hemophilia A or B
Phase 3RecruitingSuzhou Alphamab Co., Ltd.702026-03-132026-04-22
A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.
Marstacimab - Hemophilia A or B
Active not recruitingPfizer502025-10-302026-08-27
PF-06741086 Long-term Treatment in Severe Hemophilia
PF-06741086 - Hemophilia A or B
Phase 2CompletedPfizer202018-05-302021-07-27
PF-06741086 Multiple Dose Study in Severe Hemophilia
PF-06741086 - Hemophilia A or B
Phase 2CompletedPfizer272017-03-082019-12-04

Narrower conditions

Hemophilia A (5)

Broader conditions

Blood Coagulation Disorders (5)  ·  Blood Coagulation Disorders, Inherited (5)  ·  Coagulation Protein Disorders (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Genetic Diseases, Inborn (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Hemorrhagic Disorders (5)

Interventions

marstacimab (3)

Sponsors

Pfizer (3)  ·  Sanofi (1)  ·  Suzhou Alphamab Co., Ltd. (1)

Countries

United States (3)  ·  Chile (2)  ·  Croatia (2)  ·  Poland (2)  ·  South Africa (2)  ·  Switzerland (2)  ·  Brazil (1)  ·  China (1)  ·  Japan (1)

Top investigators

Changcheng Zheng, Doctor (1)  ·  Haiping Yang, Doctor (1)  ·  Hongbo Cheng, Doctor (1)  ·  Hu Zhou, Doctor (1)  ·  Jie Yin, Doctor (1)  ·  Miaoyong Zhu, Doctor (1)  ·  Qingyi Wang, Doctor (1)  ·  Renchi Yang, Doctor (1)  ·  Shu Chen, Doctor (1)  ·  Wenqian Li, Doctor (1)  ·  Xiaoli Wu, Doctor (1)  ·  Xielan Zhao (1)  ·  Yanming Zhang, Doctor (1)  ·  Yanping Song, Doctor (1)

Results publications

PMID 42698050, PMID 35999026, PMID 36220152

NIH funding

2016 (1), 2017 (1)